Global Bacterial Conjunctivitis Drugs in Development, 2021 – Find Out the R&D Progress and MoA of CTI-005, IC-702, Mul-1867, SHP-640, and More
DUBLIN, Dec. 9, 2021 /PRNewswire/ — The “Bacterial Conjunctivitis (Ophthalmology) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. This report provides an overview of the Bacterial Conjunctivitis (Ophthalmology) pipeline landscape. Companies…
Comments Off on Global Bacterial Conjunctivitis Drugs in Development, 2021 – Find Out the R&D Progress and MoA of CTI-005, IC-702, Mul-1867, SHP-640, and More